Novo Nordisk pushed for US liraglutide update as first-half sales leap
07 August 2009
Simon Varcoe
simon.varcoe@informa.com
Novo Nordisk's first-half was boosted by a 41% increase in sales in North America, with the region contributing half of the Danish company's total sales growth.
Total sales were up by 17% to DKK25.5 billion ($4.92 billion), while net profit increased by 22% to DKK5.7 billion.
The...
Please Login to read the full article.